Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Effect of EphA2 knockdown on melanoma metastasis depends on intrinsic ephrinA1 level
Jing Mo, Xiulan Zhao, Xueyi Dong, et al.
Cellular Oncology (2020) Vol. 43, Iss. 4, pp. 655-667
Closed Access | Times Cited: 22

Showing 22 citing articles:

Targeting EphA2 in cancer
Ta Xiao, Yuhang Xiao, Wenxiang Wang, et al.
Journal of Hematology & Oncology (2020) Vol. 13, Iss. 1
Open Access | Times Cited: 167
Oncogenic functions and therapeutic targeting of EphA2 in cancer
Kalin L. Wilson, Eileen Shiuan, Dana M. Brantley‐Sieders
Oncogene (2021) Vol. 40, Iss. 14, pp. 2483-2495
Open Access | Times Cited: 105
Eph receptors and ephrins in cancer progression
Elena B. Pasquale
Nature reviews. Cancer (2023) Vol. 24, Iss. 1, pp. 5-27
Open Access | Times Cited: 55
Targeting the KLF5-EphA2 axis can restrain cancer stemness and overcome chemoresistance in basal-like breast cancer
Ping Zhao, Jian Sun, Xinwei Huang, et al.
International Journal of Biological Sciences (2023) Vol. 19, Iss. 6, pp. 1861-1874
Open Access | Times Cited: 17
EphA2 on urinary extracellular vesicles as a novel biomarker for bladder cancer diagnosis and its effect on the invasiveness of bladder cancer
Eisuke Tomiyama, Kazutoshi Fujita, Kyosuke Matsuzaki, et al.
British Journal of Cancer (2022) Vol. 127, Iss. 7, pp. 1312-1323
Open Access | Times Cited: 19
Targeted internalization and activation of glycosidic switch liposomes by a biological macromolecule mPEG×EphA2 increases therapeutic efficacy against lung cancer
Kai‐Wen Ho, Yen-Ling Liu, Bo‐Cheng Huang, et al.
International Journal of Biological Macromolecules (2025), pp. 140138-140138
Closed Access
Development of an anti-human EphA2 monoclonal antibody Ea2Mab-7 for multiple applications
Hiroyuki Satofuka, Hiroyuki Suzuki, Tomohiro Tanaka, et al.
Biochemistry and Biophysics Reports (2025) Vol. 42, pp. 101998-101998
Closed Access
Role of EFNA1 in tumorigenesis and prospects for cancer therapy
Yongping Hao, Guang Li
Biomedicine & Pharmacotherapy (2020) Vol. 130, pp. 110567-110567
Open Access | Times Cited: 29
BRD4 inhibitor suppresses melanoma metastasis via the SPINK6/EGFR-EphA2 pathway
Rui Hu, Yao Li, Ying Guo, et al.
Pharmacological Research (2022) Vol. 187, pp. 106609-106609
Open Access | Times Cited: 12
Targeting the EphA2 pathway: could it be the way for bone sarcomas?
G Giordano, Cristina Tucciarello, Alessandra Merlini, et al.
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 2
lncRNA TINCR attenuates the proliferation and invasion, and enhances the apoptosis of cutaneous malignant melanoma cells by regulating the miR‑424‑5p/LATS1 axis
Xuemei Han, Yuxi Jia, Xiangru Chen, et al.
Oncology Reports (2021) Vol. 46, Iss. 5
Open Access | Times Cited: 15
TFPI2 Promotes Perivascular Migration in an Angiotropism Model of Melanoma
Jing Mo, Xiulan Zhao, Wei Wang, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 13
Exosomal EphA2 promotes tumor metastasis of triple-negative breast cancer by damaging endothelial barrier
Xin Liu, Yue Li, Chunjing Chen, et al.
Clinical & Experimental Metastasis (2022) Vol. 40, Iss. 1, pp. 105-116
Closed Access | Times Cited: 9
Expression characteristic, immune signature, and prognosis value of EFNA family identified by multi-omics integrative analysis in pan-cancer
Zonglin Jiao, Xiao Feng, Yuqing Cui, et al.
BMC Cancer (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 8
Molecular characteristics and prognostic role of EPHA2 in human tumors via pan-cancer analysis
Guoqiang Wang, Hui Xiao, Zhipan Liang, et al.
Medicine (2024) Vol. 103, Iss. 48, pp. e40741-e40741
Open Access | Times Cited: 1
An integrated analysis of single-cell and bulk transcriptomics reveals EFNA1 as a novel prognostic biomarker for cervical cancer
Xiaopeng Shen, Meng Li, Lei Yang, et al.
Human Cell (2022) Vol. 35, Iss. 2, pp. 705-720
Closed Access | Times Cited: 6
EFNA1 is a potential key gene that correlates with immune infiltration in low-grade glioma
Yongping Hao, Wenyi Wang, Qiao Qiao, et al.
Medicine (2021) Vol. 100, Iss. 22, pp. e26188-e26188
Open Access | Times Cited: 5
Prognostic value of receptor tyrosine kinases in malignant melanoma patients: A systematic review and meta-analysis of immunohistochemistry
Lei Xuan, Yiming Zhang, Lianghao Mao, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 3
Serum EphA2 as a Promising Biomarker for the Early Detection and Diagnosis of Colorectal Cancer
Shunsuke Sakuraba, Akihiro Koizumi, Takumi Iwasawa, et al.
Biomolecules (2024) Vol. 14, Iss. 12, pp. 1504-1504
Open Access
Targeted internalization and activation of glycosidic switch liposomes by an EphA2 PEG engager increases therapeutic efficacy against lung cancer
Kai‐Wen Ho, Yen-Ling Liu, Bo-Cheng Huang, et al.
Research Square (Research Square) (2024)
Open Access
An Anti-Human Epha2 Monoclonal Antibody Ea2mab-7 Shows High Sensitivity for Flow Cytometry, Western Blot, and Immunohistochemical Analyses
Hiroyuki Satofuka, Hiroyuki Suzuki, Tomohiro Tanaka, et al.
(2024)
Closed Access
Exploration of the shared pathways and common biomarkers in cervical and ovarian cancer using integrated bioinformatics analysis
Fang Liu, Min Wang, Tian Zhu, et al.
Discover Oncology (2024) Vol. 15, Iss. 1
Open Access
Page 1

Scroll to top